Prime Medicine, Inc. (PRME)
NASDAQ: PRME · Real-Time Price · USD
4.300
+0.400 (10.26%)
At close: Nov 11, 2026, 4:00 PM EST
4.290
-0.010 (-0.23%)
Pre-market: Nov 12, 2026, 7:03 AM EST
Prime Medicine Market Cap
Prime Medicine has a market cap or net worth of $764.99 million as of November 11, 2026. It is the 11,732nd most valuable company in the world and the 2,428th biggest in the United States. Its market cap has increased by 22.58% in one year.
Market Cap
764.99M
Enterprise Value
782.40M
1-Year Change
22.58%
Global Rank
Country Rank
#2,428 United States
Category
ChartMarket Cap Chart
Since the IPO on October 20, 2022, Prime Medicine's market cap has decreased from $1.63B to $764.99M, a decrease of -52.99%. That is a compound annual growth rate of -16.96%.
| Date | Market Cap | % Change |
|---|---|---|
| Nov 11, 2026 | 764.99M | 24.53% |
| Dec 31, 2025 | 614.32M | 64.88% |
| Dec 31, 2024 | 372.58M | -54.41% |
| Dec 29, 2023 | 817.15M | -49.22% |
| Dec 30, 2022 | 1.61B | -1.12% |
| Oct 20, 2022 | 1.63B | - |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| Sagimet Biosciences | 809.07M |
| Annexon | 799.30M |
| Obsidian Therapeutics | 795.63M |
| Aura Biosciences | 792.01M |
| Ardelyx | 786.80M |
| DBV Technologies | 767.85M |
| Attovia Therapeutics | 763.75M |
| Janux Therapeutics | 758.06M |